Biological Therapy

Diphtheria Toxin-Related Cytokine Fusion Proteins: A New Therapeutic Approach

Published in Blood Weekly, April 17th, 1995

Dr. John R. Murphy, Professor of Medicine in Molecular Genetics and Chief of the Section of Biomolecular Medicine at Boston University Medical Center Hospital in Boston, Massachusetts, presented updated information about the use of diptheria toxin-related cytokine fusion proteins as a form of biologic therapy at the American Cancer Society's 37th Science Writers Seminar, March 26, 1995.

Dr. Murphy explained in his briefing that the process known as receptor-mediated endocytosis provides an extremely efficient pathway for cells to internalize membrane bound macromolecules. As receptor-mediated endocytosis is a universal process, he reports that it is not surprising that...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1995-04-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry